Jun 10, 2026 07:13AM
Jun 9, 2026 07:45AM
Jun 1, 2026 07:01AM
May 11, 2026 07:03AM
Apr 22, 2026 06:39AM
Apr 15, 2026 06:59AM
Apr 13, 2026 06:40AM Actuate Therapeutics (ACTU) PT Lowered to $15 at H.C. Wainwright
Mar 24, 2026 07:01AM
Mar 24, 2026 07:00AM
Jan 15, 2026 06:45AM
Jan 6, 2026 02:26PM
Dec 15, 2025 08:45AM
Sep 23, 2025 06:37AM
Sep 22, 2025 08:45AM Actuate Therapeutics updates FDA on pancreatic cancer drug trial data
Aug 26, 2025 01:08AM
Aug 6, 2025 08:45AM
Jul 25, 2025 04:03PM
Jul 21, 2025 06:46AM
Jun 20, 2025 08:45AM
May 22, 2025 05:29PM
May 6, 2025 08:01AM Actuate Therapeutics (ACTU) Announces Statistically Significant Topline Results from Global Phase 2 Trial of Elraglusib in First-Line Treatment of MPC
Apr 22, 2025 09:02AM
Feb 25, 2025 08:04AM
Jan 7, 2025 08:03AM
Dec 17, 2024 08:02AM
Nov 12, 2024 08:04AM
Sep 11, 2024 08:00AM
Sep 9, 2024 08:01AM Actuate Therapeutics (ACTU) Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma
Jul 23, 2024 06:07AM
Jul 19, 2024 08:00AM
Jun 11, 2024 07:04AM

413,605 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All